-
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Rating of "Buy" by Analysts
Source: Buzz FX / 29 Nov 2024 03:01:10 America/Chicago
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 29, 2024 Share Link copied to clipboard. Cabaletta Bio, Inc. ( NASDAQ:CABA - Get Free Report ) has been given a consensus rating of
Read more...